Chun-Yun Sun

Chun-Yun Sun

Auto-generated profile, based on publicly available information

Chun-Yun Sun

Beijing Protein and Antibody R&D Engineering Center, Sinocelltech Ltd., Beijing 100176, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2020 in Science
Verified
Journal Article
Open access
PDF file
ZLZhe Lv
Zhe Lv
YDYongqiang Deng
Yongqiang Deng
QYQing Qing Ye
Qing Qing Ye
LCLei Cao
Lei Cao
CSChun-Yun Sun
Chun-Yun Sun
XWXiangxi Wang
Xiangxi Wang
A steric block to SARS-CoV-2: In response to infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the immune system makes antibodies, many of which target the spike protein, a key player in host cell entry. Antibodies that potently neutralize the virus hold promise as therapeutics and could inform vaccine design. Lv et al. report a humanized monoclonal antibody that protected against SARS-CoV-2 in a mouse model. The cryo–electron microscopy structure, together with biochemical, cellular, and virological studies, showed that the antibody acts by binding to the receptor-binding domain of the spike and blocking its attachment to the host receptor. Science , this issue p. 1505